# HYRIMOZ
> **BLA761071** · Biologics License Application · Sponsor: SANDOZ INC · Approved 2018-10-30
## Drug
- **FDA Application Number:** BLA761071
- **Application type:** Biologics License Application
- **Brand name:** HYRIMOZ
- **Generic name:** ADALIMUMAB-ADAZ
- **Active ingredients:** ADALIMUMAB-ADAZ
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** SANDOZ INC
- **Manufacturer:** Sandoz Inc
- **First approval:** 2018-10-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761071)
---
*MORVS · CC0 1.0*